Lee, Joo Eun
Shin, Jae Pil
Kim, Hyun Woong
Chang, Woohyok
Kim, Yu Cheol
Lee, Sang Joon
Chung, In Young
Lee, Ji Eun
Lee, Joo Eun
Shin, Jae Pil
Kim, Hyun Woong
Chang, Woohyok
Kim, Yu Cheol
Lee, Sang Joon
Chung, In Young
Kim, Kwang Soo
Park, Sung Who
Lee, Ji Eun
,
Funding for this research was provided by:
Bayer
Article History
Received: 16 June 2016
Revised: 18 August 2016
Accepted: 25 August 2016
First Online: 14 September 2016
Compliance with ethical standards
:
: Bayer Korea (Seoul, Republic of Korea) provided funding and investigational drugs for this study.
: Joo Eun Lee: consultant for Allergan, Bayer, Novartis, honorarium from Allergan, Bayer, Novartis, Alcon, research grant from Allergan, Bayer. Hyun Woong Kim: honorarium and travel grant from Bayer, Novartis. Woohyok Chang: Consultant for Bayer, Novartis, honorarium from Bayer, research grant from Novartis. Ji Eun Lee: Consultant for Allergan, Bayer, Novartis, honorarium from Allergan, Bayer, Novartis, Bausch & Lomb, research grant from Bayer. The following authors have no financial disclosures: Jae Pil Shin, Yu Cheol Kim, Sang Joon Lee, In Young Chung, Kwang Soo Kim, Sung Who Park.
: All procedure performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.